Mount Sinai Health System https://www.mountsinai.org and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program within the Regeneron Genetics Center (RGC) where enrollment is due to begin in 2022.
The goal is to provide researchers with a unique data set that will help assess the true potential of genetics-based precision medicine approaches to guide patient care and generate new insights to develop potential new therapies.
The team plans to combine the RGC’s massive gene sequencing capabilities and scientific research expertise with Mount Sinai’s large diverse patient population and use advanced EHRs systems for the project.
The Mount Sinai Program will enroll consenting patients, sequence and analyze their DNA, and then link their sequence data to anonymous versions of their EMRs for researchers to study. Patients will be recruited at the Mount Sinai Health System where about 4 million patients per year store their health data in their EMR systems.
This program will be part of other initiatives including multimodal data science, deep phenotyping of patients with informative genetic variation, and rigorously test new treatments before they are incorporated into clinical care.
Go to https://icahn.mssm.edu for more information on the Mount Sinai Million Health Discoveries Program